The THOR IDE Study

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 155 participants.

Also called NCT05916950

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 155 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT05916950
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
United States (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT05916950. Allocation not applicable; no masking; primary purpose treatment. Start 2024-10-29 (actual); primary completion 2026-12 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
The THOR IDE Study
Acronym
THOR
Condition
Peripheral Artery Disease
Condition
Peripheral Artery Stenosis
Condition
Peripheral Artery Calcification
Condition
PAD
Intervention (Device)
Thor laser atherectomy
Lead sponsor
Philips Clinical & Medical Affairs Global (class: industry)
Collaborator
NAMSA (class: other)
Collaborator
Syntropic (class: not stated)

Record details

Record id
cardio:ct-nct05916950
Content hash
023a7f5b3d50f226724998a4767e6f1ef7d7b944f7418492f07047db11c7a29a